Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-28

FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental application from Zydus Lifesciences Limited for Atenolol under ANDA 076900. This confirms approval of a generic Atenolol product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atenolol (Atenolol)

Snippet

SUPPL AP for ATENOLOL (ATENOLOL)